Penumbra Inc (PEN)

↓ Download CSV

CIK 0001321732 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Penumbra Inc reported revenue of $1.40B, up 17.5% from the prior year. The company was profitable, with a net margin of 12.7% and a gross margin of 67.1%. It held $1.83B in total assets against $398.92M in total liabilities.

Key ratios (FY2025)

67.1%
Gross margin
13.5%
Operating margin
12.7%
Net margin
12.4%
Return on equity
+17.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.40B$1.19B$1.06B$847.13M$747.59M$560.41M$547.40M$444.94M$333.76M$263.32M
Cost of Revenue$461.23M$439.62M$375.88M$311.93M$272.21M$222.24M$175.44M$152.41M$116.62M$92.49M
Gross Profit$942.44M$755.00M$682.64M$535.21M$475.38M$338.18M$371.96M$292.53M$217.14M$170.83M
Operating Income$189.25M$9.28M$73.55M$6.08M-$7.50M-$38.94M$47.51M-$852.0K$1.17M-$1.35M
Net Income$177.69M$14.01M$90.95M-$2.00M$5.28M-$15.70M$48.46M$6.60M$4.66M$14.81M
EPS (Diluted)$4.52$0.36$2.32$-0.05$0.14$-0.44$1.34$0.18$0.13$0.44
Total Assets$1.83B$1.53B$1.56B$1.37B$1.24B$822.98M$665.90M$515.01M$476.67M$308.25M
Total Liabilities$398.92M$382.25M$377.36M$372.03M$290.32M$185.19M$180.29M$92.59M$76.26M$41.71M
Shareholders' Equity$1.43B$1.15B$1.18B$998.86M$953.93M$641.50M$485.89M$422.24M$400.41M$266.55M
Cash & Equivalents$186.90M$324.40M$167.49M$69.86M$59.38M$69.67M$72.78M$67.85M$50.64M$13.24M
Operating Cash Flow$238.66M$168.48M$97.33M-$55.66M$9.50M-$33.24M$26.65M$28.81M$12.69M-$12.81M
Capital Expenditures$63.73M$21.18M$15.21M$19.30M$21.18M$24.76M$22.11M$9.60M$12.53M$13.63M
Shares Outstanding39.29M39.27M39.22M37.84M37.88M35.77M36.27M36.09M35.32M33.48M